Wilkinson Stekloff’s Pro Bono Program Highly Commended at the Chambers Diversity & Inclusion Awards

WASHINGTON, D.C. – Chambers and Partners selected Wilkinson Stekloff as Highly Commended in the Pro Bono Program of the Year Category at its annual Diversity and Inclusion Awards: North America 2020. This is the second year in a row that Chambers and Partners has recognized Wilkinson Stekloff’s acclaimed pro bono program. In July 2020, Chambers shortlisted Wilkinson Stekloff as an outstanding firm for diversity and inclusion and as one of its private practice pro bono programs of the year.  Chambers then specifically recognized Wilkinson Stekloff as operating one of the two best pro bono programs out of all law firms in the entire country, large and small. “Since the beginning, we have been committed to pro bono and to ensuring that everyone has an opportunity at achieving fair and equal justice,” said Partner Tamarra Matthews Johnson. “We are honored to be recognized by Chambers and Partners for our outstanding pro …

Missouri Department of Corrections Required to Provide Lifesaving Hepatitis C Treatment to Thousands Behind Bars

Wilkinson Stekloff, ACLU of Missouri, and Macarthur Justice Center reach landmark settlement requiring Hepatitis C treatment and education Washington, D.C. – Today, Wilkinson Stekloff LLP announced a landmark settlement, ensuring that people incarcerated in Missouri’s prisons will receive life-saving Hepatitis C treatment and education. Wilkinson Stekloff brought its trial expertise to the case after class certification was affirmed by the Eighth Circuit, joining the ACLU of Missouri and the Roderick and Solange MacArthur Justice Center to litigate the case in district court for the plaintiffs and achieve a successful resolution.  In June 2019, Wilkinson Stekloff and its co-counsel filed a motion for preliminary injunction, seeking to require the Missouri Department of Corrections and its private medical services contractor, Corizon LLC, to begin treating class members immediately.  The Wilkinson Stekloff team recruited a roster of credentialed experts from around the country to offer evidence in support of Plaintiffs’ motion.  At a …

Wilkinson Stekloff Celebrates Another Outstanding Year of High Stakes Trials and Accolades for the Next Generation of Trial Lawyers

WASHINGTON –Wilkinson Stekloff enters its fifth year having cemented its status as the premier trial litigation boutique in the country. 2019 featured three high-stakes, high-pressure trials, in which different partners served as lead trial counsel and eight partners in total had stand-up roles. The firm continued to receive accolades for its successes in delivering results to its clients while deepening its diverse bench of go-to litigators.

Wilkinson Stekloff Celebrates Banner Year of High Stakes Trial Wins By Next Generation Of Trial Lawyers

WASHINGTON – Wilkinson Stekloff is racing into its fourth year after notching a series of high-profile victories, led by a large and diverse group of partners. In 2018, all of Wilkinson Stekloff’s partners participated in trials and case-dispositive hearings, and several other attorneys achieved significant on-their-feet experience, including through pro bono cases. The firm earned repeated recognition for the depth and successes of its bench and added a new crop of talented litigators to its roster. Wilkinson Stekloff won three trials in 2018, each of which was first-chaired by a different partner: On April 27, 2018, Wilkinson Stekloff, led by Brian Stekloff, Jeremy Barber, and Lori McGill, won a unanimous defense verdict for Bayer and Johnson & Johnson subsidiary Janssen Pharmaceuticals in Russell v. Janssen Pharmaceuticals, Inc., the second state-court Xarelto bellwether trial in the Pennsylvania Court of Common Pleas. On May 21, 2018, Wilkinson Stekloff, led by Kosta Stojilkovic …

Wilkinson Stekloff Secures Another Trial Victory for Bayer in Xarelto Trial

Alexandra Walsh, co-founding partner of Wilkinson, Walsh + Eskovitz, Tamarra Matthews Johnson, and Rakesh Kilaru led the defense team to another victory. WASHINGTON – The Wilkinson Stekloff trial team, led by Founding Partner Alexandra Walsh and partners Tamarra Matthews Johnson and Rakesh Kilaru, won the third state-court bellwether trial over the blood- thinner Xarelto in the Pennsylvania Court of Common Pleas. This is the third win for Bayer in state court, and the sixth win overall, in the Xarelto litigation. The Plaintiff, Kevin Cooney, alleged that Bayer and Johnson & Johnson subsidiary Janssen Pharmaceuticals were liable for claims that the Xarelto label did not adequately warn or instruct doctors on the risks of bleeding associated with the anticoagulant medicine Xarelto. Walsh and Johnson served as lead trial counsel for Bayer, and Kilaru helped direct the legal strategy. A 12-member jury in Philadelphia returned a defense verdict after less than three …

Wilkinson Stekloff Adds Tamarra Matthews Johnson as Partner

Matthews Johnson is latest high-profile addition to top boutique trial firm WASHINGTON – Wilkinson Stekloff today announced the addition of Tamarra Matthews Johnson as a partner in its Washington, D.C. office. In just 18 months, Wilkinson Stekloff has grown to nearly 40 lawyers, and quickly established itself as the leading boutique trial firm in the country.  Matthews Johnson, an experienced litigator at both the appellate and trial level, joins the firm as partner. Throughout her career, she has tried complex civil and criminal cases, and clerked for Supreme Court Justice Sandra Day O’Connor. Tamarra is the firm’s tenth partner, and seventh former Supreme Court clerk. “I could not be more excited to re-enter private practice as a partner of Wilkinson Stekloff,” said Ms. Matthews Johnson. “I’m thrilled to be able to call such an impressive group of trial lawyers my colleagues—and the firm’s innovative approach to trying cases is a …